Page last updated: 2024-08-18

pyrroles and maytansine

pyrroles has been researched along with maytansine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Dimasi, N; Gregson, SJ; Herbst, R; Howard, PW; Kiefer, CM; Kinneer, K; Masterson, L; Meekin, J; Moriarty, A; Papadopoulos, KP; Phipps, S; Rebelatto, MC; Sridhar, S; Tai, YT; Tiberghien, AC; Tice, DA; Wick, MJ	1

Other Studies

1 other study(ies) available for pyrroles and maytansine

Article	Year
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads. Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 12-15, Volume: 24, Issue:24 Topics: Animals; Antineoplastic Agents, Immunological; Benzodiazepines; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Gene Expression; Gene Silencing; Humans; Immunoconjugates; Maytansine; Melanoma, Experimental; Mice; Pyrroles; Xenograft Model Antitumor Assays	2018

Article

Year

SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 12-15, Volume: 24, Issue:24

Topics: Animals; Antineoplastic Agents, Immunological; Benzodiazepines; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Gene Expression; Gene Silencing; Humans; Immunoconjugates; Maytansine; Melanoma, Experimental; Mice; Pyrroles; Xenograft Model Antitumor Assays

2018